BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6219578)

  • 1. Comparative study of available medical therapy for hypercalcemia of malignancy.
    Mundy GR; Wilkinson R; Heath DA
    Am J Med; 1983 Mar; 74(3):421-32. PubMed ID: 6219578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.
    Gucalp R; Ritch P; Wiernik PH; Sarma PR; Keller A; Richman SP; Tauer K; Neidhart J; Mallette LE; Siegel R
    J Clin Oncol; 1992 Jan; 10(1):134-42. PubMed ID: 1727915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disodium pamidronate versus mithramycin in the management of tumour-associated hypercalcemia.
    Ostenstad B; Andersen OK
    Acta Oncol; 1992; 31(8):861-4. PubMed ID: 1290634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.
    Ralston SH; Gardner MD; Dryburgh FJ; Jenkins AS; Cowan RA; Boyle IT
    Lancet; 1985 Oct; 2(8461):907-10. PubMed ID: 2865417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diphosphonates in the treatment of hypercalcemia].
    Delmas PD; Meunier PJ
    Rev Med Interne; 1984 Nov; 5(4):363-6. PubMed ID: 6240753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective evaluation of the medical treatment of malignancy-associated hypercalcemia.
    Kimura S; Sato Y; Matsubara H; Adachi I; Yamaguchi K; Suzuki M; Suemasu K; Abe K
    Jpn J Cancer Res; 1986 Jan; 77(1):85-91. PubMed ID: 2937761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disodium pamidronate (APD) in therapy of hypercalcemia in primary hyperparathyroidism].
    Kotzmann H; Svoboda T; Bernecker P; Clodi M; Woloszczuk W; Niederle B; Waldhäusl W; Luger A
    Wien Klin Wochenschr; 1994; 106(13):422-5. PubMed ID: 8091766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of malignancy-associated hypercalcemia: 1983.
    Stewart AF
    Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of hypercalcemia.
    Kukreja SC
    Compr Ther; 1980 Aug; 6(8):33-8. PubMed ID: 6447571
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hypercalcemia of tumoral origin with two diphosphonates].
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Schweiz Med Wochenschr; 1980 Nov; 110(48):1822-4. PubMed ID: 6792698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer agents for the treatment of malignant hypercalcemia.
    Kinirons MT
    Am J Med Sci; 1993 Jun; 305(6):403-6. PubMed ID: 8506902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.
    van Breukelen FJ; Bijvoet OL; Frijlink WB; Sleeboom HP; Mulder H; van Oosterom AT
    Calcif Tissue Int; 1982 Jul; 34(4):321-7. PubMed ID: 6814719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
    Tal A; Graves L
    South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypercalcaemia of malignancy.
    Heath DA
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):139-45. PubMed ID: 2143893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.
    Nussbaum SR; Younger J; Vandepol CJ; Gagel RF; Zubler MA; Chapman R; Henderson IC; Mallette LE
    Am J Med; 1993 Sep; 95(3):297-304. PubMed ID: 8368227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the medical treatment of hypercalcemia of malignancy.
    Hall TG; Schaiff RA
    Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management strategies for hypercalcemia.
    Pecherstorfer M; Brenner K; Zojer N
    Treat Endocrinol; 2003; 2(4):273-92. PubMed ID: 15966562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial.
    Thürlimann B; Waldburger R; Senn HJ; Thiébaud D
    Ann Oncol; 1992 Sep; 3(8):619-23. PubMed ID: 1450043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcemia of malignancy: diagnosis and therapy.
    Fetchick DA; Mundy GR
    Compr Ther; 1986 Aug; 12(8):27-32. PubMed ID: 2943551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phosphate treatment in hypercalcemia].
    Kistler HJ; Neubauer W
    Klin Wochenschr; 1970 Jun; 48(12):741-52. PubMed ID: 5524894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.